AUTISM
FDA Modifies Prescribing Information for Contraceptive Skin Patch The FDA issued a notice that it modified the prescribing information for the Ortho Evra Contraceptive Transdermal Patch to include the results of a new epidemiological study that found women who used the birth control patch were at a higher risk of developing venous thromboembolism (VTE) than those who used birth control pills.